FDA Struggles to Keep Lights On Amid Shutdown as Biopharmas Begin To See Delays

While the FDA continues to put out guidance documents and approve drugs, some companies are already reporting delays in dealings with the agency, while insiders warn of falling morale and a negative perception from the rest of the biopharma world.